marketcaparena
Search

    SCNX

    Scienture Holdings, Inc.

    Company overview

    Market capitalization
    $11.07M
    Employees
    4
    Latest publication
    2026-09-29
    About Scienture Holdings, Inc.

    Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue343,639USD-168,699USD590,050USD0USD10,258USD53,083USD64,861USD18,699USD
    Cost Of Revenue7,860USD75,113USD15,429USD15,457USD9,585USD50,258USD60,978USD19,402USD
    Gross Profit335,779USD-243,812USD574,621USD-15,457USD673USD2,825USD3,883USD-703USD
    Research Development1,166,605USD368,698USD169,344USD843,549USD574,679USD982,707USD1,253,983USD86,674USD
    Selling General Administrative368,790USD2,537,376USD4,756,727USD4,292,949USD2,935,691USD3,114,132USD2,090,217USD1,408,314USD
    General And Administrative Expenses368,790USD———————
    Total Operating Expenses3,035,512USD2,910,551USD4,935,827USD5,157,906USD3,571,990USD4,217,387USD3,501,674USD1,494,988USD
    Operating Income-2,699,733USD-3,154,363USD-4,361,206USD-5,157,906USD-3,571,317USD-4,214,562USD-3,497,791USD-1,495,691USD
    Total Other Income Expense Net-122,638USD-26,960,848USD753,845USD-1,562,667USD507,320USD-3,122,550USD314,190USD-129,050USD
    Interest Expense269,785USD955,499USD1,803,430USD653,493USD670,784USD1,014,734USD217,433USD4,949USD
    Litigation Settlement Expense117,815USD———————
    Net Income-2,822,371USD-28,120,333USD-3,607,361USD-6,720,573USD-3,063,997USD-7,162,732USD-3,183,601USD-1,833,902USD
    Interest Income—212,992USD1,120USD63,148USD25,442USD1,940USD29,445USD41,031USD
    Net Interest Income—-742,507USD-1,802,310USD-590,345USD-645,342USD-1,012,794USD-187,988USD36,082USD
    Income Before Tax—-30,115,211USD-3,607,361USD-6,720,573USD-3,063,997USD-7,337,112USD-3,183,601USD-1,624,741USD
    Income Tax Expense—-1,994,878USD———-534,396USD——
    Tax Provision—-1,994,878USD0USD0USD0USD—0USD0USD
    Net Income From Continuing Ops—-28,120,333USD-3,607,361USD-6,720,573USD-3,063,997USD-6,802,716USD-3,183,601USD-1,624,741USD
    Ebit—-29,159,712USD-1,803,931USD-6,067,080USD-2,393,213USD-6,322,378USD-2,966,168USD-1,619,792USD
    Ebitda—-28,705,366USD-1,796,977USD-6,051,623USD-2,378,189USD-6,308,319USD-2,943,532USD-1,611,429USD
    Depreciation And Amortization—454,346USD6,954USD15,457USD15,024USD14,059USD22,636USD8,363USD
    Reconciled Depreciation—454,346USD6,954USD15,457USD15,024USD14,059USD22,636USD8,363USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USD
    Total Revenue431,609USD7,436,264USD3,831,778USD2,931,280USD2,481,866USD2,912,525USD1,496,227USD955,881USD
    Cost Of Revenue100,127USD2,565,500USD449,049USD—16,362USD189,838USD440,047USD944,070USD
    Gross Profit331,482USD4,870,764USD3,382,729USD2,931,280USD2,465,504USD2,722,687USD1,056,180USD11,811USD
    Research Development1,956,270USD—949,948USD863,324USD————
    Selling General Administrative14,522,743USD4,377,020USD3,470,345USD1,405,026USD3,341,515USD———
    Total Operating Expenses16,576,274USD4,745,540USD3,470,345USD2,536,185USD3,472,783USD2,859,757USD2,487,652USD2,095,815USD
    Operating Income-16,244,792USD125,224USD-87,616USD395,095USD-1,007,279USD-137,070USD-1,431,472USD-2,084,004USD
    Interest Income302,702USD———————
    Interest Expense4,083,206USD53,227USD57,541USD157,056USD151,500USD119,512USD4,154USD7,281USD
    Net Interest Income-3,780,504USD———————
    Income Before Tax-43,507,142USD-284,428USD9,038USD288,983USD-1,173,108USD-256,582USD-2,012,043USD-2,091,285USD
    Income Tax Expense-1,994,878USD———————
    Tax Provision-1,994,878USD———————
    Net Income-41,512,264USD-284,428USD9,038USD288,983USD-2,760,125USD-1,117,183USD-2,012,043USD-2,091,285USD
    Net Income From Continuing Ops-41,512,264USD———————
    Ebit-39,423,936USD-231,201USD-87,616USD395,095USD-1,007,279USD-137,070USD-2,007,889USD-2,084,004USD
    Ebitda-38,932,155USD-136,470USD66,579USD446,039USD-1,021,608USD-133,268USD-2,003,089USD-2,080,017USD
    Depreciation And Amortization491,781USD94,731USD———3,802USD4,800USD3,987USD
    Reconciled Depreciation491,781USD———————
    Total Other Income Expense Net-27,262,350USD-409,652USD96,654USD-106,112USD-165,829USD-119,512USD-580,571USD-7,281USD
    Unclassified Operating Expenses—————2,859,757USD2,487,652USD2,095,815USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets87,734,007USD84,178,330USD104,830,290USD104,294,834USD106,358,530USD104,853,805USD94,259,693USD14,848,533USD
    Cash And Equivalents8,188,140USD———————
    Total Current Assets9,201,897USD7,916,406USD1,421,074USD856,625USD7,825,226USD6,305,477USD7,255,916USD12,144,444USD
    Total Liabilities23,632,481USD———————
    Total Current Liabilities3,026,300USD2,735,351USD7,351,446USD7,688,199USD7,461,665USD7,906,893USD5,413,438USD2,902,089USD
    Other Current Liabilities503,634USD———————
    Total Stockholder Equity64,101,526USD70,120,384USD82,669,631USD77,860,463USD81,162,760USD79,072,121USD85,132,041USD11,785,448USD
    Total Equity Including Noncontrolling Interest64,101,526USD———————
    Net Receivables385,313USD731,328USD590,050USD62,500USD5,347,503USD5,449,876USD5,816,227USD3,543,888USD
    Inventory203,074USD213,408USD234,521USD——0USD7,884USD6,439USD
    Property Plant Equipment Net16,968USD38,860USD39,360USD46,314USD203,909USD218,933USD232,991USD182,050USD
    Intangible Assets70,065,371USD70,973,064USD76,400,000USD76,400,000USD76,400,000USD76,400,000USD76,400,000USD—
    Accounts Payable916,771USD1,443,266USD3,672,860USD3,136,436USD3,184,771USD2,898,683USD2,904,081USD726,266USD
    Short Term Debt2,546USD24,137USD2,555,137USD2,543,056USD2,580,843USD2,763,757USD325,882USD65,215USD
    Common Stock410USD406USD231USD161USD125USD87USD86USD14USD
    Retained Earnings-86,775,872USD-80,551,237USD-52,430,904USD-48,823,543USD-42,102,970USD-39,038,973USD-31,876,241USD-26,504,881USD
    Other Current Assets—309,662USD240,811USD841,234USD428,085USD547,505USD852,702USD874,124USD
    Total Liab—14,057,946USD22,160,659USD26,434,371USD25,195,770USD25,781,684USD9,127,652USD3,063,085USD
    Other Current Liab—1,267,948USD1,123,449USD2,008,707USD1,696,051USD2,244,453USD2,183,475USD2,143,215USD
    Capital Stock—406USD231USD161USD125USD87USD86USD14USD
    Good Will—0USD21,372,960USD21,372,960USD21,372,960USD21,372,960USD7,848,747USD—
    Cash—6,662,008USD355,692USD15,391USD2,049,638USD308,096USD579,103USD7,719,993USD
    Cash And Short Term Investments—6,662,008USD355,692USD15,391USD2,049,638USD308,096USD579,103USD7,719,993USD
    Net Debt—-6,637,871USD2,199,445USD4,108,195USD1,762,585USD3,224,405USD2,175,993USD-7,526,389USD
    Short Long Term Debt Total—24,137USD2,555,137USD4,123,586USD3,812,223USD3,532,501USD2,755,096USD193,604USD
    Property Plant Equipment Gross—38,860USD39,360USD46,314USD203,909USD218,933USD232,991USD182,050USD
    Common Stock Shares Outstanding—153,473,000shares18,957,653shares14,141,443shares9,425,751shares8,750,582shares2,373,848shares2,377,646shares
    Non Current Assets Total—76,261,924USD103,409,216USD103,438,209USD98,533,304USD98,548,328USD87,003,777USD2,704,089USD
    Non Current Liabilities Total—11,322,595USD14,809,213USD18,746,172USD17,734,105USD17,874,791USD3,714,214USD160,996USD
    Non Current Liabilities Other—285,000USD1,285,000USD1,285,001USD1,285,000USD1,285,000USD1,285,000USD—
    Non Currrent Assets Other—5,250,000USD5,062,500USD5,084,539USD22,039USD22,039USD22,039USD22,039USD
    Net Working Capital—5,181,055USD-5,930,372USD-6,831,574USD363,561USD-1,601,416USD1,842,478USD9,242,355USD
    Unclassified Non Current Liabilities—11,037,595USD13,524,213USD15,883,187USD15,356,644USD15,977,516USD——
    Unclassified Equity—150,670,809USD135,100,073USD126,683,684USD123,265,480USD118,110,920USD117,008,110USD38,290,301USD
    Short Long Term Debt——2,531,000USD2,515,000USD2,515,000USD2,700,423USD265,000USD—
    Unclassified Current Liabilities——-2,531,000USD-2,515,000USD-2,515,000USD-2,700,423USD——
    Long Term Debt———1,577,984USD1,092,461USD612,275USD2,255,848USD—
    Long Term Investments——————2,500,000USD2,500,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets84,178,330USD104,853,805USD12,532,913USD3,710,026USD5,766,164USD9,792,702USD5,571,494USD2,227,587USD
    Intangible Assets70,973,064USD76,400,000USD8,962,688USD—————
    Other Current Assets309,662USD547,505USD227,079USD302,785USD216,414USD151,248USD82,452USD82,927USD
    Total Liab14,057,946USD25,781,684USD11,990,560USD3,367,159USD1,995,991USD1,113,544USD1,431,277USD1,382,919USD
    Total Stockholder Equity70,120,384USD79,072,121USD542,353USD763,136USD3,770,173USD8,679,158USD4,140,217USD844,668USD
    Other Current Liab1,267,948USD2,244,453USD3,530,746USD1,250,141USD540,874USD219,256USD98,852USD138,323USD
    Common Stock406USD87USD9USD6USD82USD81USD65USD55USD
    Capital Stock406USD87USD9USD6USD82USD81USD——
    Retained Earnings-80,551,237USD-39,038,973USD-33,245,940USD-19,719,536USD-16,247,437USD-10,931,554USD-8,395,503USD-8,111,075USD
    Good Will0USD21,372,960USD0USD——0USD725,973USD725,973USD
    Cash6,662,008USD308,096USD314USD1,094,894USD3,122,578USD5,919,578USD2,871,694USD869,557USD
    Cash And Short Term Investments6,662,008USD308,096USD314USD1,094,894USD3,122,578USD5,919,578USD2,871,694USD869,557USD
    Total Current Assets7,916,406USD6,305,477USD2,753,063USD2,093,123USD4,374,244USD9,221,298USD3,802,957USD1,466,077USD
    Total Current Liabilities2,735,351USD7,906,893USD11,556,355USD2,146,791USD926,026USD842,238USD520,816USD860,367USD
    Net Debt-6,637,871USD3,224,405USD6,764,190USD489,013USD-1,874,052USD-5,292,119USD-1,873,883USD-25,505USD
    Short Term Debt24,137USD2,763,757USD6,562,595USD363,539USD357,122USD356,153USD87,350USD321,500USD
    Short Long Term Debt Total24,137USD3,532,501USD6,764,504USD1,583,907USD1,248,526USD627,459USD997,811USD844,052USD
    Net Receivables731,328USD5,449,876USD2,524,702USD629,921USD978,973USD1,892,718USD792,050USD433,627USD
    Inventory213,408USD0USD968USD65,523USD56,279USD1,257,754USD56,761USD79,966USD
    Accounts Payable1,443,266USD2,898,683USD1,463,014USD527,984USD477,028USD256,829USD334,614USD400,544USD
    Property Plant Equipment Net38,860USD218,933USD198,716USD1,117,029USD1,331,784USD549,768USD932,697USD15,006USD
    Property Plant Equipment Gross38,860USD218,933USD198,716USD1,117,029USD1,331,784USD549,768USD——
    Common Stock Shares Outstanding153,473,000shares3,653,609shares2,381,443shares564,863shares542,449shares513,708shares395,272shares388,350shares
    Non Current Assets Total76,261,924USD98,548,328USD9,779,850USD1,616,903USD1,391,920USD571,404USD1,768,537USD761,510USD
    Non Current Liabilities Total11,322,595USD17,874,791USD434,205USD1,220,368USD1,069,965USD271,306USD910,461USD522,552USD
    Non Current Liabilities Other285,000USD1,285,000USD——————
    Non Currrent Assets Other5,250,000USD22,039USD618,446USD499,874USD60,136USD21,636USD109,867USD20,531USD
    Net Working Capital5,181,055USD-1,601,416USD-8,803,292USD-53,668USD3,448,218USD8,379,060USD——
    Unclassified Non Current Liabilities11,037,595USD15,977,516USD——1,069,965USD———
    Unclassified Equity150,670,809USD118,110,920USD33,788,275USD20,482,660USD20,017,446USD19,610,550USD12,535,655USD8,955,688USD
    Short Long Term Debt—2,700,423USD6,530,000USD166,667USD—225,000USD——
    Long Term Debt—612,275USD25,000USD333,333USD————
    Unclassified Current Liabilities—-2,700,423USD-6,530,000USD—————
    Current Deferred Revenue———5,127USD—10,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation929,585USD
    Stock Based Compensation205,777USD
    Change To Account Receivables346,015USD
    Change To Inventory10,334USD
    Change To Liabilities-679,895USD
    Change In Working Capital-333,238USD
    Operating Cash Flow-6,051,597USD
    Financing Cash Flow10,590,000USD
    Change In Cash4,538,403USD
    End Cash Flow11,200,411USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income-3,402,264USD-3,607,361USD-6,720,573USD-3,063,997USD-6,802,716USD-3,183,601USD-1,833,902USD-6,633,422USD
    Depreciation468,013USD6,954USD15,457USD15,024USD14,059USD22,636USD8,363USD8,303USD
    Stock Based Compensation102,320,000USD1,820,433USD————444USD4,450,919USD
    Other Non Cash Items-2,344USD1,219,926USD4,267,179USD436,893USD2,414,015USD405,612USD-57,691USD223,713USD
    Change To Account Receivables8,783USD-590,050USD-171,735USD102,372USD366,351USD-2,272,339USD-14,646USD-7,815,208USD
    Change To Inventory2,474USD-234,521USD0USD0USD7,884USD-1,445USD-1,067USD-4,404USD
    Change In Working Capital17,340USD-833,204USD403,690USD-344,377USD1,465,229USD-2,632,755USD6,104,741USD-8,239,186USD
    Total Cash From Operating Activities-2,919,255USD-3,213,685USD-2,034,247USD-2,956,457USD-2,909,413USD-5,388,108USD4,221,955USD-10,189,673USD
    Capital Expenditures-5USD-5USD-3USD-3USD-3USD-12,002USD-5USD-3USD
    Free Cash Flow-2,919,260USD-3,213,680USD-2,034,250USD-2,956,460USD-2,909,410USD-5,400,110USD4,221,955USD-10,189,670USD
    Net Borrowings0USD-3,317,333USD0USD100,000USD2,790,000USD314,000USD——
    Total Cash From Financing Activities-200,000USD3,553,986USD0USD4,697,999USD2,790,000USD-1,873,759USD0USD-13,896,011USD
    Issuance Of Capital Stock0USD6,871,319USD0USD4,597,999USD—0USD0USD0USD
    Change In Cash-3,119,254USD340,301USD-2,034,246USD1,741,541USD-271,007USD-7,140,890USD4,221,181USD3,498,498USD
    Begin Period Cash Flow6,662,008USD15,391USD2,049,637USD308,096USD579,103USD7,719,993USD3,498,812USD314USD
    End Period Cash Flow3,542,754USD355,692USD15,391USD2,049,637USD308,096USD579,103USD7,719,993USD3,498,812USD
    Other Cashflows From Financing Activities-200,000USD3,553,986USD———314,000USD—-1,251,346USD
    Unclassified Operating Cash Flow-102,320,000USD-1,820,433USD——————
    Investments—0USD0USD0USD0USD120,976USD-774USD27,432,589USD
    Dividends Paid—0USD0USD0USD0USD-2,187,759USD0USD-12,671,072USD
    Unclassified Financing Cash Flow—-3,553,986USD——————
    Other Cashflows From Investing Activities————-2,500,000USD2,500,000USD-774USD29,932,589USD
    Total Cashflows From Investing Activities—————120,976USD-774USD27,432,589USD
    Unclassified Investing Cash Flow—————-2,487,998USD—-29,932,586USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Net Income-18,244,480USD-8,482,864USD-2,403,442USD-5,315,883USD-2,536,051USD-284,428USD9,038USD288,983USD
    Depreciation53,361USD1,049,830USD194,704USD138,909USD102,520USD94,731USD——
    Stock Based Compensation25,584USD257,772USD254,106USD181,163USD1,357,759USD———
    Other Non Cash Items6,525,451USD-563,177USD132,382USD1,344,809USD2,459,821USD999,328USD179,695USD385,538USD
    Change To Account Receivables-2,925,174USD-548,708USD-505,318USD298,088USD-23,532USD-369,923USD-1,532USD-20,354USD
    Change To Inventory968USD4,232,947USD-51,737USD825,127USD-2,419,013USD23,205USD-3,810USD—
    Change In Working Capital-2,599,571USD5,513,247USD257,582USD1,084,776USD-3,598,835USD-667,856USD84,653USD-502,851USD
    Total Cash From Operating Activities-14,265,239USD-2,225,192USD-1,564,668USD-2,566,226USD-2,214,786USD141,775USD273,386USD171,670USD
    Capital Expenditures-12,001USD-2USD-450,845USD-22,596USD-37,505USD-82,252USD-15,006USD0USD
    Free Cash Flow-14,277,240USD-2,225,190USD-1,564,668USD-2,588,822USD-2,252,291USD59,523USD258,380USD171,670USD
    Investments27,552,791USD-275,717USD-427,845USD-22,596USD-37,505USD———
    Total Cashflows From Investing Activities27,552,791USD-275,717USD-427,845USD-22,596USD-37,505USD-332,252USD-265,279USD—
    Net Borrowings3,104,000USD250,000USD0USD-225,000USD————
    Total Cash From Financing Activities-12,979,770USD1,406,332USD-35,171USD-208,178USD5,300,175USD2,192,614USD677,536USD-2,435USD
    Dividends Paid-14,858,831USD0USD——————
    Issuance Of Capital Stock0USD0USD130,918USD0USD5,994,424USD———
    Change In Cash307,782USD-1,094,580USD-2,027,684USD-2,797,000USD3,047,884USD2,002,137USD685,643USD169,235USD
    Begin Period Cash Flow314USD1,094,894USD3,122,578USD5,919,578USD2,871,694USD869,557USD183,914USD14,679USD
    End Period Cash Flow308,096USD314USD1,094,894USD3,122,578USD5,919,578USD2,871,694USD869,557USD183,914USD
    Other Cashflows From Investing Activities27,431,815USD68,737USD23,000USD—————
    Other Cashflows From Financing Activities-1,251,346USD638,310USD-166,089USD16,822USD-694,249USD166USD—250USD
    Unclassified Investing Cash Flow-27,419,814USD———————
    Unclassified Financing Cash Flow—————2,192,448USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2023Yearly · 2023-12-31ProductProduct Revenue1,850,851USD0001493152-24-015595
    FY 2023Yearly · 2023-12-31ProductService Revenue6,421,363USD0001493152-24-015595
    FY 2023Yearly · 2023-12-31SegmentAll Other Segments19,204USD0001493152-24-015595
    FY 2023Yearly · 2023-12-31SegmentIntegra1,363,830USD0001493152-24-015595
    FY 2023Yearly · 2023-12-31SegmentSuperlatus487,021USD0001493152-24-015595
    FY 2023Yearly · 2023-12-31SegmentTrxade Inc6,402,159USD0001493152-24-015595
    Q3 2023Quarterly · 2023-09-30ProductProduct Revenue394,849USD0001493152-24-002429
    Q3 2023Quarterly · 2023-09-30ProductService Revenue1,663,179USD0001493152-24-002429
    Q1 2023Quarterly · 2023-03-31ProductProduct Revenue476,356USD0001493152-24-025217
    Q1 2023Quarterly · 2023-03-31ProductService Revenue16,960USD0001493152-24-025217
    Q1 2023Quarterly · 2023-03-31SegmentIntegra476,356USD0001493152-24-025217
    Q1 2023Quarterly · 2023-03-31SegmentUnallocated Segments16,960USD0001493152-24-025217
    FY 2022Yearly · 2022-12-31ProductProduct Revenue4,754,067USD0001493152-24-015595
    FY 2022Yearly · 2022-12-31ProductService Revenue5,496,101USD0001493152-24-015595
    FY 2022Yearly · 2022-12-31SegmentAll Other Segments60,287USD0001493152-24-015595
    FY 2022Yearly · 2022-12-31SegmentIntegra4,754,067USD0001493152-24-015595
    FY 2022Yearly · 2022-12-31SegmentTrxade Inc5,435,814USD0001493152-24-015595
    Q3 2022Quarterly · 2022-09-30ProductProduct Revenue707,807USD0001493152-24-002429
    Q3 2022Quarterly · 2022-09-30ProductService Revenue1,347,996USD0001493152-24-002429
    Q1 2022Quarterly · 2022-03-31SegmentAll Other Segments22,372USD0001493152-23-017524
    Q1 2022Quarterly · 2022-03-31SegmentCommunity Specialty Pharmacy LLC268,407USD0001493152-23-017524
    Q1 2022Quarterly · 2022-03-31SegmentIntegra Pharma LLC1,567,530USD0001493152-23-017524
    Q1 2022Quarterly · 2022-03-31SegmentTrxade Inc1,381,963USD0001493152-23-017524
    FY 2021Yearly · 2021-12-31SegmentAll Other Segments62,016USD0001493152-23-009090
    FY 2021Yearly · 2021-12-31SegmentCommunity Specialty Pharmacy LLC1,652,841USD0001493152-23-009090
    FY 2021Yearly · 2021-12-31SegmentIntegra Pharma LLC3,250,561USD0001493152-23-009090
    FY 2021Yearly · 2021-12-31SegmentTrxade Inc4,924,015USD0001493152-23-009090
    Q1 2021Quarterly · 2021-03-31SegmentAll Other Segments16,103USD0001493152-22-012529
    Q1 2021Quarterly · 2021-03-31SegmentCommunity Specialty Pharmacy LLC397,896USD0001493152-22-012529
    Q1 2021Quarterly · 2021-03-31SegmentIntegra Pharma LLC1,402,586USD0001493152-22-012529
    Q1 2021Quarterly · 2021-03-31SegmentTrxade Inc1,236,650USD0001493152-22-012529
    FY 2020Yearly · 2020-12-31SegmentAll Other Segments44,783USD0001493152-22-007879
    FY 2020Yearly · 2020-12-31SegmentCommunity Specialty Pharmacy LLC1,653,924USD0001493152-22-007879
    FY 2020Yearly · 2020-12-31SegmentIntegra Pharma LLC9,877,067USD0001493152-22-007879
    FY 2020Yearly · 2020-12-31SegmentTrxade Inc5,546,746USD0001493152-22-007879
    Q1 2020Quarterly · 2020-03-31SegmentAll Other Segments5,468USD0001493152-21-009653
    Q1 2020Quarterly · 2020-03-31SegmentCommunity Specialty Pharmacy LLC432,929USD0001493152-21-009653
    Q1 2020Quarterly · 2020-03-31SegmentIntegra Pharma LLC245,016USD0001493152-21-009653
    Q1 2020Quarterly · 2020-03-31SegmentTrxade Inc1,519,907USD0001493152-21-009653
    FY 2019Yearly · 2019-12-31SegmentCommunity Specialty Pharmacy LLC1,888,086USD0001493152-21-007052
    FY 2019Yearly · 2019-12-31SegmentIntegra Pharma LLC1,020,438USD0001493152-21-007052
    FY 2019Yearly · 2019-12-31SegmentTrxade Inc4,527,740USD0001493152-21-007052
    Q1 2019Quarterly · 2019-03-31SegmentCommunity Specialty Pharmacy LLC442,423USD0001493152-20-007589
    Q1 2019Quarterly · 2019-03-31SegmentIntegra Pharma LLC26,288USD0001493152-20-007589
    Q1 2019Quarterly · 2019-03-31SegmentTrxade Inc1,043,810USD0001493152-20-007589
    FY 2018Yearly · 2018-12-31SegmentCommunity Specialty Pharmacy LLC395,418USD0001493152-20-005026
    FY 2018Yearly · 2018-12-31SegmentIntegra Pharma LLC28,538USD0001493152-20-005026
    FY 2018Yearly · 2018-12-31SegmentTrxade Inc3,407,822USD0001493152-20-005026

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.